In summary, we have carried out a novel study showing that the hepatic expression of OLFM2 seems to increase as NAFLD progresses, and this protein seems to be associated with NASH and with a severe steatosis pattern in NAFLD patients. This evidence concerns the gene OLFM2 and metabolic dysfunction-associated steatohepatitis.